Share on Pinterest The FDA has approved an esketamine nasal spray for the treatment of depression cases that do not respond to other therapeutic approaches. Image credit: Koldunov/Getty Images.
The Food and Drug Administration (FDA) recently approved the nasal spray Spravato for the treatment of MDD in those who have not responded to at least two oral antidepressants. Hundreds of ...
Bumetanide Nasal Spray (RSQ-777) is being developed as a convenient, outpatient-focused therapy for edema associated with congestive heart failure, as well as liver and kidney disease.
The FDA's expanded approval will allow the drug to be more accessible with insurance. Parkside Psychiatric Hospital in Tulsa has an on-site Spravato outpatient clinic that sees over 20 patients ...
For patients with allergic rhinitis, twice-daily azelastine plus fluticasone cut nasal symptoms ... all treatments were administered as one spray twice daily to preserve blinding.
We don't think so. No matter whether you're camping or hanging out in your backyard, it's paramount that you bring protection against the wilds with bug spray. In fact, if you travel to a country ...
Even the best diets can have vitamin and nutrient gaps. Fill the gaps by making high-quality vitamins a part of your regular routine. There are many options for supplements out there to help with ...
Background: Hairdressers are at risk for occupational respiratory diseases, but the risk factors, causal agents, and underlying mechanisms are not completely defined. Aim: To describe the features ...